CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
  • Product Pipeline
    • Collink.3D Bioinks
      • Collink.3D 50
      • Collink.3D 50L
      • Collink.3D 90
    • Gut-on-a-Chip
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Sustainability
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Mar 26, 2024 8:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 15, 2024 8:00am EST

CollPlant Issues Letter to Shareholders

Jan 08, 2024 7:18am EST

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 02, 2024 7:00am EST

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Nov 29, 2023 7:00am EST

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

Nov 09, 2023 8:00am EST

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 01, 2023 7:05am EDT

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

Sep 21, 2023 7:00am EDT

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

Sep 05, 2023 7:00am EDT

CollPlant to Present at the H.C. Wainwright Annual Growth Conference

Aug 24, 2023 7:00am EDT

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...18
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Details

    exploreCollPlant Ltd

    4 Oppenheimer Street
    P.O. Box 4132
    Rehovot 7670104, Israel

    LinkedinLinkedIn YoutubeYoutube TwitterTwitter
    local_phone+972 73 2325600
    local_printshop+972 73 2325602
    mailinfo@collplant.com

     
     

    ® 2025 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20